Publicaciones en colaboración con investigadores/as de Universidad Rey Juan Carlos (17)

2024

  1. Editorial: Current trends on emotional processing: contributions of acquired brain injury, neurodegenerative diseases, and ageing

    Frontiers in Psychology

  2. N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia

    Translational Psychiatry, Vol. 14, Núm. 1

2023

  1. Neighborhood Vulnerability and Disability in First Episode of Psychosis: A Multilevel Study

    The Journal of clinical psychiatry, Vol. 84, Núm. 2

  2. Neuroimaging Revealed Long-Lasting Glucose Metabolism Changes to Morphine Withdrawal in Rats Pretreated with the Cannabinoid Agonist CP-55,940 during Periadolescence

    European Neuropsychopharmacology, Vol. 69, pp. 60-76

2022

  1. The effects of mango leaf extract during adolescence and adulthood in a rat model of schizophrenia

    Frontiers in Pharmacology, Vol. 13

  2. The relationship between negative symptoms, social cognition, and social functioning in patients with first episode psychosis

    Journal of Psychiatric Research, Vol. 155, pp. 171-179

2021

  1. A Characterization of the Effects of Minocycline Treatment during Adolescence on Structural, Metabolic, and Oxidative Stress Parameters in a Maternal Immune Stimulation Model of Neurodevelopmental Brain Disorders

    International Journal of Neuropsychopharmacology, Vol. 24, Núm. 9, pp. 734-748

  2. Analogues of cannabinoids as multitarget drugs in the treatment of Alzheimer's disease

    European Journal of Pharmacology, Vol. 895

2017

  1. Synthesis of a novel CB2 cannabinoid-porphyrin conjugate based on an antitumor chromenopyrazoledione

    Journal of Porphyrins and Phthalocyanines, Vol. 21, Núm. 1, pp. 67-76

2014

  1. Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 73, pp. 56-72

  2. Combining rimonabant and fentanyl in a single entity: Preparation and pharmacological results

    Drug Design, Development and Therapy, Vol. 8, pp. 263-277

  3. Subcellular distribution and early signalling events of P2X7 receptors from mouse cerebellar granule neurons

    European Journal of Pharmacology, Vol. 744, pp. 190-202

2013

  1. Description of a bivalent cannabinoid ligand with hypophagic properties

    Archiv der Pharmazie, Vol. 346, Núm. 3, pp. 171-179

2012

  1. Chromenopyrazoles: Non-psychoactive and Selective CB 1 Cannabinoid Agonists with Peripheral Antinociceptive Properties

    ChemMedChem, Vol. 7, Núm. 3, pp. 452-463

  2. Daidzein has neuroprotective effects through ligand-binding-independent PPARγ activation

    Neurochemistry International, Vol. 61, Núm. 1, pp. 119-127

2011

  1. Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia-reperfusion injury in Zucker diabetic fatty rats: Role of CB2 receptors and iNOS/eNOS

    Diabetes/Metabolism Research and Reviews, Vol. 27, Núm. 4, pp. 331-340

2003

  1. New benzimidazole derivatives: Selective and orally active 5-HT3 receptor antagonists

    European Journal of Pharmacology, Vol. 462, Núm. 1-3, pp. 99-107